A gene that greatly increases a woman's risk of breast cancer also causes a particularly deadly form of prostate cancer, say Canadian researchers who studied 301 prostate cancer patients. On average, those with the defective BRCA2 gene lived an average of four years after diagnosis. The average survival time for prostate cancer patients is 12 years.
